Drug Target Tools: How Metabolomics Reduces Risks in Drug Development

In both pre-clinical cell and animal models and human clinical trial subjects, biomarkers that reveal deep insights into the drug’s efficacy and mechanism(s) of action are a cornerstone for informing decision-making at every step of drug development. The insights provided by biomarkers also enrich powerful model-based drug discovery. This book will focus on using metabolomics throughout the R&D process as an ally to improve clinical success.